CASI Pharmaceuticals (United States)

Recent papers from CASI Pharmaceuticals (United States)

1. Supporting the Supporters. A Systematic Scoping Review of Support Interventions for Informal CaregiversHome Health Care Management & Practice · 2026
2. Astrocytic APOE3-Christchurch expression ameliorates brain amyloid-β pathology in 5xFAD miceTranslational Psychiatry · 2026
3. Digital Informal Care: The Use of Technology in Family Care. A Scoping ReviewPublic health reviews · 2026
4. The critical elements of digital health in diabetes and cardiometabolic careFrontiers in Endocrinology · 2024
5. The Development and Potential Applications of an Automated Method for Detecting and Classifying Continuous Glucose Monitoring PatternsJournal of Diabetes Science and Technology · 2024
6. Impact of a Combined Continuous Glucose Monitoring–Digital Health Solution on Glucose Metrics and Self-Management Behavior for Adults With Type 2 Diabetes: Real-World, Observational StudyJMIR Diabetes · 2023
7. Data from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of ENMD-2076, a Novel Angiogenic and Aurora Kinase Inhibitor,in Patients with Advanced Solid Tumors2023
8. Data from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of ENMD-2076, a Novel Angiogenic and Aurora Kinase Inhibitor,in Patients with Advanced Solid Tumors2023
9. Impact of a Combined Continuous Glucose Monitoring–Digital Health Solution on Glucose Metrics and Self-Management Behavior for Adults With Type 2 Diabetes: Real-World, Observational Study (Preprint)2023
10. Transcriptome profiling reveals that VNPP433‐3β, the lead next‐generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial–mesenchymal transition and stem cell markersMolecular Carcinogenesis · 2022
11. Complementarity of Digital Health and Peer Support: “This Is What’s Coming”Frontiers in Clinical Diabetes and Healthcare · 2021
12. A New Taxonomy for Technology-Enabled Diabetes Self-Management Interventions: Results of an Umbrella ReviewJournal of Diabetes Science and Technology · 2021
13. Engagement and Outcomes Associated with Contextual Annotation Features of a Digital Health SolutionJournal of Diabetes Science and Technology · 2020
14. Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar CarcinomaThe Oncologist · 2020
15. Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 TherapyIn Vivo · 2020
16. First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast CancerMolecular Cancer Therapeutics · 2019
17. Induced pluripotent stem cells for treating cystic fibrosis: State of the sciencePediatric Pulmonology · 2018
18. A multi-case study of instructional decision-making processes of teachers in kindergarten classrooms within the Cape Coast Metropolis, GhanaRevista Brasileira de Gestão Ambiental e Sustentabilidade · 2018
19. 2017 National Standards for Diabetes Self-Management Education and SupportDiabetes Spectrum · 2017
20. 2017 National Standards for Diabetes Self-Management Education and SupportDiabetes Care · 2017